PTH-responsive osteoblast nuclear matrix architectural transcription factor binds to the rat type I collagen promoter

Journal of Cellular Biochemistry

Volumn 69, Issue 3, 1998, Pages 336-352

  Alvarez, Marta ^a   Thunyakitpisal, Pasutha ^a   Morrison, Paul ^a   Onyia, Jude ^a,b   Hock, Janet ^a,b   Bidwell, Joseph P ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Architectural transcription factor; Nuclear matrix; Osteoblast; Parathyroid hormone; Type collagen

Indexed keywords

COLLAGEN TYPE 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL NUCLEUS MATRIX; DNA STRUCTURE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; RAT; TRANSCRIPTION REGULATION;

EID: 0032104825     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980601)69:3<336::AID-JCB11>3.0.CO;2-A     Document Type: Article

References (61)

1. Abu-Daya A, Brown PM, Fox KR (1995): DNA sequence preference of several AT-selective minor groove binding ligands. Nucleic Acids Res 23:3385-3392.
2. Ali NN, Melhuish PB, Boyde A, Bennet A, Jones SJ (1990): Parathyroid hormone, but not prostaglandin E2, changes the shape of osteoblasts maintained on bone in vitro. J Bone Miner Res 5:115-121.
3. Alvarez M, Onyia J, Hock J, Long H, Xu W, Bidwell J (1997): Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 138:482-489.
4. Aubin JE, Alders E, Heersche JMN (1983): A primary role for microfilaments but not microtubules in hormone induced cytoplasmic retraction. Exp Cell Res 143:439-450.
5. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl D (eds) (1987): "Current Protocols in Molecular Biology." New York: John Wiley & Sons, Inc.
6. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS (1996): An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sei U S A 93:4968-4973.
7. Bedalov A, Salvatori R, Dodig M, Kronenberg MS, Kapural B, Bogdanovic Z, Kream BE, Woody CO, Clark SH, Mack K, Rowe DW, Lichtler AC (1995): Regulation of COL1A1 expression in type I collagen producing tissues: Identifcation of a 49 base pair region which is required for transgene expression in bone of transgenic mice. J Bone Miner Res 10:1443-1451.
8. Benya PD (1988): Modulation and reexpression of the chondrocyte phenotype; mediation by cell shape and microfilament modification. Pathology and Immunopathology Research 7:51-54.
9. Benya PD, Shaffer JD (1982): Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30:215-224.
10. Bidwell J, Feister H, Swartz D, Onyia J, Holden J, Hock J (1996): Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins. J Cell Biochem 63:374-383.
11. Bode J, Kohwi Y, Dickinson L, Joh T, Klehr K, Mielke C, Kohwi-Shigematsu T (1992): Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255:195-197.
12. Bogdanovic Z, Bedalov A, Krebsbach PH, Pavlin D, Woody CO, Clark SH, Thomas HF, Rowe DW, Kream BE, Lichtler AC (1994): Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res 9:285-292.
13. Boulikas T (1995): Chromatin domains and prediction of MAR sequences. Int Rev Cytol 162A:279-388.
14. Bronner F, Stein WD (1992): Modulation of bone calcium-binding sites regulates plasma calcium: An hypothesis. Calcif Tissue Int 50:483-489.
15. Churchill MEA, Travers AA (1991): Protein motifs that recognize structural features of DNA. Trends Biochem Sci 16:92-97.
16. Cockell M, Frutiger S, Hughes GJ, Gasser SM (1994): The yeast protein encoded by PUB1 binds T-rich single stranded DNA. Nucleic Acids Res 22:32-40.
17. Compton DA, Cleveland DW (1994): NuMA, a nuclear protein involved in mitosis and nuclear reformation. Current Opin Cell Biol 6:343-346.
18. Davie JR (1995): The nuclear matrix and the regulation of chromatin organization and function. Int Rev Cytol 162A: 191-250.
19. Dempster DW, Cosman F, Parisien M, Shen V, Lindgay R (1993): Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709.
20. Dhawan J, Lichtler AC, Rowe DW, Farmer SR (1991): Cell adhesion regulates pro-al(I) collagen mRNA stability and transcription in mouse fibroblasts. J Biol Chem 266:8470-8475.
21. Dickinson LA, Kohwi-Shigematsu T (1995): Nucleolin is a matrix-attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential. Mol Cell Biol 15:456-465.
22. Diegelmann RF, Peterkofsky B (1972): Inhibition of collagen secretion from bone and cultured fibroblasts by microtubule disruptive drugs. Proc Natl Acad Sci U S A 69:892-896.
23. Dignam JD, Lebovitz RM, Roeder RG (1983): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
24. Dobnig H, Turner R (1995): Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
25. Dodig M, Kronenberg MS, Bedalov A, Kream BE, Gronowicz G, Clark SH, Mack K, Liu YH, Maxon R, Pan ZZ, Upholt WB, Rowe DW, Lichtler AC (1996): Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J Biol Chem 271:16422-16429.
26. Egan JJ, Grononwicz G, Rodan G (1991): Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: Mediation by cyclic AMP. J Cell Biochem 45:101-111.
27. Ferrari S, Harley VR, Pontiggia A, Goodfellow PN, Lovell-Badge R, Bianchi ME (1992): SRY, like HMG1, recognizes sharp angles in DNA. EMBO J 11:4497-4506.
28. Ferrier J, Ward-Kesthely A, Heersche JN, Aubin JE (1988): Membrane potential changes, cAMP stimulation and contraction in osteoblast-like UMR 106 cells in response to calcitonin and parathyroid hormone. Bone Miner 4:133-145.
29. Forrester WC, Genderen Cv, Jenuwein T, Grosschedl R (1994): Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions. Science 265:1221-1225.
30. Giese K, Cox J, Grosschedl R (1992): The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185-195.
31. Giese K, Kingsley C, Kirshner JR, Grosschedl R (1995): Assembly and function of a TCRa enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9:995-1008.
32. Grosschedl R, Giese K, Pagel J (1994): HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures. Trends Genet 10:94-100.
33. Hakes DJ, Berezney R (1991): DNA binding properties of the nuclear matrix and individual nuclear matrix proteins. Evidence for salt-resistant DNA binding sites. J Biol Chem 266:11131-11140.
34. Herrscher RF, Kaplan MH, Lesz DL, Das C Scheuermann R, Tucker PW (1995): The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev 9:3067-3082.
35. Hertzberg RP, Dervan PB (1984): Cleavage of DNA with Methidiumpropyl-EDTA-Iron(II): Reaction conditions and product analyses. Biochemistry 23:3934-3945.
36. Hofmann JFX, Gasser SM (1991): Identification and purification of a protein that binds the yeast ARS consensus sequence. Cell 64:951-960.
37. Kerppola TK, Curran T (1993): Selective DNA bending by a variety of bZIP proteins. Mol Cell Biol 13:5479-5489.
38. Kim J, Zwieb C, Wu C, Adhya S (1989): Bending of DNA by gene-regulatory proteins: Construction and use of a DNA bending vector. Gene 85:15-23.
39. Kohwi-Shigematsu T, Kohwi Y (1990): Torsional stress stabilizes extended base unpairing in suppressor sites flanking immunoglobulin heavy chain enhancer. Biochemistry 29:9551-9560.
40. Kream BE, LaFrancis D, Petersen DN, Woody C, Clark S, Rowe DW, Lichtler A (1993): Parathyroid hormone represses a1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice. Mol Endocrinol 7:399-108.
41. Lormi A, Marie PJ (1990): Changes in cytoskeletal proteins in response to parathyroid hormone and 1,25-dihydroxyvitamin D in human osteoblastic cells. Bone Miner 10: 1-12.
42. Maniotis AJ, Chen CS, Ingber DE (1997): Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci U S A 94:849-854.
43. Mirkovitch J, Mirault M-E, Laemmli UK (1984): Organization of the higher order chromatin loop: Specific DNA attachment sites on nuclear scaffold. Cell 39:223-232.
44. Nakagomi K, Kohwi Y, Dickinson LA, Kohwi-Shigematsu T (1994): A novel DNA-binding motif in the nuclear matrix attachment DNA-binding protein SATB1. Mol Cell Biol 14:1852-1860.
45. Nickerson JA, Blencowe BJ, Penman S (1995): The architectural organization of nuclear metabolism. Int Rev Cytol 162A:67-123.
46. Partridge NC, Dickson CA, Kopp K, Teitelbaum SL, Crouch EC, Kahn AJ (1989): Parathyroid hormone inhibits collagen synthesis at both ribonucleic acid and protein levels in rat osteogenic sarcoma cells. Mol Endocrinol 3:232-239.
47. Phi-Van L, von Kries JP, Ostertag W, Strätling WH (1990): The chicken lysozyme 5' matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. Mol Cell Biol 10:2302-2307.
48. Pienta KJ, Hoover CN (1994): Coupling of cell structure to cell metabolism and function. J Cell Biochem 55:16-21.
49. Pienta KJ, Getzenberg RH, Coffey DH (1991): Cell structure and DNA organization. Eukaryotic Gene Expression 1:355-385.
50. Scherft JP, Heersche JNM (1975): Accumulation of collagen containing vacuoles in osteoblasts after administration of colchicine. Cell Tissue Res 157:353-365.
51. Schmidhauser C, Casperson GF, Myers CA, Sanzo KT, Bolten S, Bissel MJ (1992): A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of β-casein gene expression. Mol Biol Cell 3:699-709.
52. Schmidt AM, Herterich SU, Krauss G (1991): A single-stranded DNA binding protein from S. cerevisiae specifically recognizes the T-rich strand of the core sequence of ARS elements and discriminates against mutant sequences. EMBO J 10:981-985.
53. Schmidt IU, Dobnig H, Turner RT (1995): Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formaiton in tibial metaphysis of hypophysectomized female rats. Endocrinology 136: 5127-34.
54. Thompson JF, Landy A (1988): Empirical estimation of protein-induced DNA bending angles: Applications to lambda site-specific recombination complexes. Nucleic Acids Res 16:9687-9705.
55. Torrungruang K, Feister F, Swartz D, Hancock EB, Hock J, Bidwell JP (1998): Parathyroid hormone (PTH) regulates the expression of the nuclear mitotic apparatus protein (NuMA) in the osteoblast-like cells, ROS 17/2.8. Bone (in press).
56. van der Vliet PC, Verrijzer CP (1993): Bending of DNA by transcription factors. Bioessays 15:25-32.
57. Verrijzer CP, van Oosterhout JAWM, van Weperen WW, van der Vliet PC (1991): POU proteins bend DNA via the POU-specific domain. EMBO J 10:3007-3014.
58. Whitfield JF, Morley P (1995): Small bone-building fragments of parathyroid hormone: New therapeutic agents for osteoporosis. Trends Pharmacol Sci 16:382-386.
59. Wolffe AP (1994): Architectural transcription factors. Science 264:1100-1101.
60. Wu HM, Crothers DM (1984): The locus of sequence-directed and protein-induced DNA bending. Nature 308: 509-513.
61. Zeng C, He D, Brinkley BR (1994): Localization of NuMA protein isoforms in the nuclear matrix of mammalian cells. Cell Motil Cytoskeleton 29:167-176.